Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS | 6 | 7 | -0,04 % | ||
| SAREPTA THERAPEUTICS | 5 | 1 | -0,31 % | ||
| INCYTE | 4 | 25 | +0,40 % | ||
| WAVE LIFE SCIENCES | 3 | 2 | -4,88 % | ||
| REGENERON PHARMACEUTICALS | 2 | 22 | -0,36 % | ||
| BIONTECH | 2 | 13 | -0,11 % | ||
| CORMEDIX | 2 | 10 | -2,54 % | ||
| VERTEX PHARMACEUTICALS | 2 | 5 | -0,34 % | ||
| ENLIVEN THERAPEUTICS | 2 | 2 | -1,53 % | ||
| PROTHENA | 2 | 1 | -0,40 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:42 | Notable analyst calls this week: Sarepta, Cisco and UBS among top picks | 2 | Seeking Alpha | ||
| 14:42 | Vertex posts additional trial data for type 1 diabetes therapy | 5 | Seeking Alpha | ||
| 10:30 | SONDERMELDUNG bei Biontech: Könnte der Kurs am Montag komplett einbrechen - Das sagen die Experten! | Hebelschein-Spekulant | |||
| 01:36 | Structure Therapeutics Inc.: Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671 | 2 | GlobeNewswire (USA) | ||
| Fr | Tevogen files to sell 30.73M shares of common stock for holders | 2 | Seeking Alpha | ||
| Fr | CARGO Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions | 5 | Insider Monkey | ||
| Fr | Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake | 7 | Insider Monkey | ||
| Fr | Ionis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to Retire | 3 | Insider Monkey | ||
| Fr | Truist Initiates PTC Therapeutics (PTCT) Coverage with Buy Rating on Drug Launches | 3 | Insider Monkey | ||
| Fr | Citi Rates Protagonist Therapeutics (PTGX) as Buy Protagonists Drugs Opportunity | 2 | Insider Monkey | ||
| Fr | Atea Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Biomea Fusion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today | 6 | Benzinga.com | ||
| Fr | Inozyme Pharma Inc.: Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders | 2 | GlobeNewswire (USA) | ||
| Fr | Incyte says FDA delays target action date for ruxolitinib cream | 3 | Seeking Alpha | ||
| Fr | FDA extends review period for Incyte's atopic dermatitis cream | 3 | Investing.com | ||
| Fr | ImmunityBio, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| Fr | Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 20 | GlobeNewswire (Europe) | NOVATO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for... ► Artikel lesen | |
| Fr | Wave Life Sciences präsentiert vielversprechende Daten zu Adipositas-Behandlung | 1 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .